Перегляд за автором "Cherviakova, S.A."

Результати 1-5 з 5

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease

Tronko, M.D.; Cherviakova, S.A.; Pushkarev, V.V.; Belchina, Y.B.; Kovzun, O.I.; Pushkarev, V.M.; Sokolova, L.K. (Доповіді НАН України, 2021)

Increased levels of high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A1 (ApoA1) in plasma is associated with a reduced risk of developing cardiovascular diseases (CVD). In addition to its potential ...
Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19

Tronko, M.D.; Cherviakova, S.A.; Pushkarev, V.V.; Belchina, Y.B.; Kovzun, O.I.; Pushkarev, V.M.; Sokolova, L.K. (Доповіді НАН України, 2021)

Elevated levels of low-density lipoprotein (LDL-X) cholesterol, apolipoprotein B (ApoB), and especially oxidized LDL in plasma are associated with an increased risk of cardiovascular disease (CVD). The aim of the study ...
Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients

Tronko, M.D.; Pushkarev, V.V.; Sokolova, L.K.; Cherviakova, S.A.; Belchina, Y.B.; Kovzun, O.I.; Guda, B.B.; Pushkarev, V.M. (Доповіді НАН України, 2022)

The aim of the study was to determine the levels of AMPKα1 and IRS-1 in the blood of patients with diabetes mellitus and COVID-19. AMPKα1 and IRS-1 were determined using enzyme-linked immunosorbent assay (ELISA) ...
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients

Tronko, M.D.; Pushkarev, V.V.; Sokolova, L.K.; Cherviakova, S.A.; Belchina, Yu.B.; Kovzun, O.I.; Pushkarev, V.M. (Доповіді НАН України, 2021)

Insulin receptor substrate (IRS) is a key adapter protein mediating effects of insulin and insulin-like growth factors (IGF) in cells. IRS-1 is a member of the insulin receptor substrate family, which is associated with ...
NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment

Sokolova, L.K.; Pushkarev, V.M.; Belchina, Yu.B.; Pushkarev, V.V.; Furmanova, O.V.; Cherviakova, S.A.; Kovzun, O.I.; Tronko, M.D. (Доповіді НАН України, 2018)

The content of the brain natriuretic peptide (NT-proBNP) in blood plasma and the activity of 5′-adenosine monophosphate- activated protein kinase (AMPK) in lymphocytes of type 2 diabetes patients with anemia and after the ...

Результати 1-5 з 5

Пошук

Розширений пошук

Перегляд

Вся бібліотека

Перегляд за автором "Cherviakova, S.A."

Репозиторій DSpace/Manakin

Перегляд за автором "Cherviakova, S.A."

Пошук

Перегляд

Вся бібліотека

Мій обліковий запис